Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis

Go back to Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis
Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) Delayed: 10.95 +0.14 (1.30%)
Previous Close $10.81    52 Week High $135.54 
Open $11.06    52 Week Low $94.36 
Day High $11.09    P/E N/A 
Day Low $10.91    EPS $0.00 
Volume 389,366       

Bayer AG (AMEX: BAYZF) Delayed: 44.07 +0.91 (2.11%)
Previous Close $43.16    52 Week High $135.00 
Open $44.24    52 Week Low $94.95 
Day High $44.24    P/E N/A 
Day Low $44.07    EPS $0.00 
Volume 1,255